Litcius/Paper detail

Maternal FADS2 single nucleotide polymorphism modified the impact of prenatal docosahexaenoic acid (DHA) supplementation on child neurodevelopment at 5 years: Follow-up of a randomized clinical trial

Inés González-Casanova, Meriah Schoen, Sonia Tandon, Aryeh D. Stein, Albino Barraza‐Villarreal, Ann DiGirolamo, Hans Demmelmair, Ivonne Ramírez‐Silva, Raquel Garcia Feregrino, Peter Rzehak, India C. Stevenson, Marie Standl, Lourdes Schnaas, Isabelle Romieu, Berthold Koletzko, Usha Ramakrishnan

2021Clinical Nutrition12 citationsDOIOpen Access PDF

Topics & Concepts

FADS2Docosahexaenoic acidOffspringMedicineSingle-nucleotide polymorphismPolyunsaturated fatty acidRandomized controlled trialPrenatal carePregnancyInternal medicinePediatricsGenotypeFatty acidGeneticsBiologyBiochemistryPopulationGeneEnvironmental healthFatty Acid Research and HealthAntioxidant Activity and Oxidative StressVitamin C and Antioxidants Research
Maternal FADS2 single nucleotide polymorphism modified the impact of prenatal docosahexaenoic acid (DHA) supplementation on child neurodevelopment at 5 years: Follow-up of a randomized clinical trial | Litcius